Aleve® Teams Up with HGTV’s Dave and Jenny Marrs for New Project DIY Campaign
Aleve Launches Project DIY Campaign Featuring Dave and Jenny Marrs to Celebrate Passion Projects and Long-Lasting Pain Relief Aleve®, one of the leading over-the-counter pain relief brands, has unveiled a…
FUJIFILM and HORIBA Partner to Develop High-Sensitivity Inline Raman System for Biopharmaceutical Manufacturing
Fujifilm and HORIBA Co-Develop High-Sensitivity Inline Raman Measurement System to Advance Biopharmaceutical Manufacturing FUJIFILM Corporation and HORIBA, Ltd. have announced the joint development of a high-sensitivity inline Raman measurement system…
Guided Therapeutics Submits Clinical Report for Premarket Approval Application to FDA
Guided Therapeutics Submits Positive LuViva Clinical Trial Results to FDA, Demonstrating Enhanced Detection of Precancerous Cervical Disease Guided Therapeutics, Inc., a medical technology company focused on improving cervical cancer detection…
Emmecell Announces Successful Closing of Strategic Funding Transaction
Emmecell Secures Strategic Financing to Advance Magnetic Cell Delivery Technology for Ophthalmic Diseases Emmecell, a clinical-stage biotechnology company focused on developing innovative magnetic cell delivery technologies for the treatment of…
Simulations Plus to Join Altaris in Approximately $375 Million Buyout Deal
Simulations Plus Agrees to $375 Million Acquisition by Altaris, Signaling New Chapter in AI-Driven Drug Development Simulations Plus, Inc., a recognized leader in model-informed drug development and artificial intelligence-enabled pharmaceutical…
Pelago Bioscience Acquires RG Discovery to Expand Integrated Drug Discovery Capabilities
Pelago Bioscience Expands Drug Discovery Capabilities Through Acquisition of RG Discovery Pelago Bioscience, a leading contract research organization (CRO) specializing in cell-based target engagement technologies, has announced the acquisition of…
Takeda’s Oveporexton Improves Daily Function and Sleep in Narcolepsy Type 1
Takeda Presents New Phase 3 Data Showing Oveporexton Improves Daily Functioning, Cognition, and Sleep in Narcolepsy Type 1 Takeda has unveiled additional findings from its pivotal Phase 3 clinical development…
OM Pharma to Present Major Broncho-Vaxom Real-World Study at EAACI 2026
OM Pharma Presents Preliminary REACH Study Findings Demonstrating Real-World Benefits of Broncho-Vaxom® in Preventing Recurrent Respiratory Tract Infections OM Pharma has announced the presentation of preliminary results from its landmark…
Incyte Showcases Pivotal Tafasitamab Results at EHA 2026 Plenary
Incyte Reports Positive Phase 3 frontMIND Results Showing Tafasitamab and Lenalidomide Plus R-CHOP Improves Outcomes in High-Risk DLBCL and HGBL Incyte has announced positive results from its pivotal Phase 3…
Biocytogen Achieves Full AAALAC Accreditation, Strengthening Research Excellence
Biocytogen’s Boston Research Facility Earns AAALAC International Full Accreditation, Reinforcing Commitment to Scientific Excellence and Animal Welfare Biocytogen has announced a significant achievement for its U.S. research operations, revealing that…
Sumitomo Pharma Presents New Hematology Data at EHA 2026
Sumitomo Pharma America Highlights New Clinical and Translational Research for Nuvisertib and Enzomenib at EHA 2026 Sumitomo Pharma America, Inc. (SMPA) has unveiled new clinical and translational research findings at…
Cellares Secures Additional $50 Million Investment, Bringing Series D Round to $327 Million
Cellares Secures Additional $50 Million Investment, Expanding Series D Financing to $327 Million to Accelerate Global Cell Therapy Manufacturing Network Cellares, the world’s first Integrated Development and Manufacturing Organization (IDMO)…